Non-antimicrobial drugs tied to drug-resistant bacterial infection
Jul 19, 2021
Proton pump inhibitors, beta-blockers, antimetabolites linked to infection with antibiotic-resistant bacteria
48.3 percent of U.S. population over 16 has at least one dose of COVID-19 vaccine
Jul 15, 2021
As of May 15, 2021, coverage was lower for non-Hispanic Blacks and Hispanics versus Whites; higher for those at risk for severe COVID-19
House committees to investigate new Alzheimer’s disease drug approval
Jul 01, 2021
FDA approved Aduhelm earlier this month, despite advisory committee’s conclusion that there was not enough evidence to support its effectiveness
COVID-19 falls from America’s No. 1 killer to No. 7 by June
Jul 01, 2021
(HealthDay News) — A steep rise in vaccination rates has dropped COVID-19 from the first to the seventh leading cause of death in the United States, a new analysis shows. The disease was the third leading...
Physician knowledge linked to less opioid prescribing in 2015 to 2017
Jul 01, 2021
(HealthDay News) — During 2015 to 2017, physician knowledge was associated with less frequent prescribing of opioids for back pain, according to a study published online July 1 in JAMA Network Open....
Heart failure linked to increased incidence of cancer
Jun 29, 2021
Increased rates of cancer seen among women and men and for cancer at multiple sites, including lip, oral cavity, pharynx, respiratory organs
ADA: Efpeglenatide lowers risk for adverse CV events in T2DM
Jun 29, 2021
(HealthDay News) — For patients with type 2 diabetes and a history of cardiovascular disease or current kidney disease, the risk for adverse cardiovascular events is lower with efpeglenatide, an exendin-based...
ADA: Tirzepatide non-inferior, superior to Semaglutide for T2DM
Jun 29, 2021
Greater reduction in glycated hemoglobin levels and improved weight loss seen with tirzepatide in type 2 diabetes
Patients do not improve activity level after hip replacement
Jun 17, 2021
Findings despite surgery success in aiding pain, physical performance